Products for Research Use Only

Human Factor Alpha-XIIa

CAT: 0952-B2013625Size: 0.5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0952-B2013625Size:0.5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Human Factor Alpha-XIIa_x000D_ Catalog number: B2013625_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 0.5 mg_x000D_ Molecular Weight or Concentration: 80 kDa_x000D_ Supplied as: Solution_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: Human Factor Alpha-XIIa_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Brandt M, Gerke V, Betz T. Human endothelial cells display a rapid tensional stress increase in response to tumor necrosis factor-α PLoS One. 2022 Jun 24;17(6):e0270197._x000D_ 2: Van Setten GB, Edstrom L, Stibler H, Rasmussen S, Schultz G. Levels of transforming growth factor alpha (TGF-alpha) in human cerebrospinal fluid Int J Dev Neurosci. 1999 Apr;17(2):131-4._x000D_ 3: Smith JM, Sporn MB, Roberts AB, Derynck R, Winkler ME, Gregory H. Human transforming growth factor-alpha causes precocious eyelid opening in newborn mice Nature. 1985 Jun 6-12;315(6019):515-6._x000D_ 4: Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures Implement Sci. 2017 Aug 29;12(1):108._x000D_ 5: Takashiba S, Van Dyke TE, Shapira L, Amar S. Lipopolysaccharide-inducible and salicylate-sensitive nuclear factor(s) on human tumor necrosis factor alpha promoter Infect Immun. 1995 Apr;63(4):1529-34._x000D_ 6: Lu Z, Wang G, Dunstan CR, Zreiqat H. Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation Stem Cells Dev. 2012 Sep 1;21(13):2420-9._x000D_ 7: Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat Proc Natl Acad Sci U S A. 1989 Aug;86(15):5974-8._x000D_ 8: Ciacci-Woolwine F, Kucera LS, Richardson SH, Iyer NP, Mizel SB. Salmonellae activate tumor necrosis factor alpha production in a human promonocytic cell line via a released polypeptide Infect Immun. 1997 Nov;65(11):4624-33._x000D_ 9: Sone S, Munekata M, Tanaka M, Utsugi T, Ogura T. Effector mechanism of human monocyte-mediated cytotoxicity: role of a new tumor cytotoxic factor distinct from interleukin 1 and tumor necrosis factor alpha Biotherapy. 1989;1(3):233-43._x000D_ 10: Li YP, Pei YY, Zhou ZH, Zhang XY, Gu ZH, Ding J, Gao XJ, Zhu JH. PEGylated recombinant human tumor necrosis factor alpha: pharmacokinetics and anti-tumor effects Biol Pharm Bull. 2001 Jun;24(6):666-70. _x000D_ _x000D_ Products Related to Human Factor Alpha-XIIa can be found at Proteins
Short Description
Catalog Number: B2013625 (0.5 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5